CJ Bioscience, Inc. provides microbiome solutions for unmet medical needs in South Korea and internationally. Its platform, Ez-Mx, is a bioinformatics-based system for microbiome data analysis. The product pipeline includes CJRB-101 in Phase I trials for solid tumors, CJRB-201, CJRB-202, and CJRB-203 for inflammatory bowel diseases, CJRB-302 for Parkinson's disease, and CJRB-401 and CJRB-402 for asthma. The company also offers next-generation sequencing analysis services, EzBioCloud (a database and bioinformatics analysis portal for microbial research), EzBioCloud Pro (a next-generation analysis platform for infection diagnosis and microbial bioinformatics), Gut Inside (a microbiome testing service), and TrueBac ID (a cloud-based service platform for identifying bacterial species from genomic data). Formerly known as ChunLab, Inc., it changed its name to CJ Bioscience, Inc. in December 2021. Founded in 2009, the company is based in Seoul, South Korea.